Vision & Mission

The main purpose of Hera-MI is to use Artificial Intelligence (AI) to help early-stage breast cancer diagnosis in order to optimize patient care and save millions of women worldwide.

Our ambition is to speed up and improve breast cancer diagnosis thanks to the development of clinical decision support solutions.

Hera-MI has developed Breast-SlimView, a patented clinical decision support solution for 2D/3D mammography.

Breast Cancer

Artificial Intelligence


Dedicated to radiologists and patients

Speed up and improve breast cancer diagnosis thanks to

Artificial Intelligence in order to save millions of women

Free yourselves from irrelevant information
and detect suspicious areas at a glance

Request a demo

Breast-SlimView offers an innovative and disruptive reading solution where only relevant information is displayed


EC Mark Approval

Hera-MI received EC mark approval

View more

International Pitch Challenge

Hera-MI won the 1st price

View more

SIFEM 2019

Flashback on SIFEM 2019 with Dr. Malika Grebici

View more

A patented clinical decision solution
for 2D/3D mammography


Meet us at tradeshows, conferences, and events.


Find more


Find scientific articles on Artificial Intelligence

in radiology and breast cancer

Find more

A faster and improved breast cancer diagnosis

Subscribe to our newsletter

Get more information and keep informed about Hera-MI and Breast-SlimView by subscribing to our newsletter.

Follow us